2019 International Congress Archives - Page 2 of 217

11C-PBB3 PET in PD: does alpha-synuclein pathology start in axonal terminals?

M. Matarazzo, A. Pérez-Soriano, V. Sossi, N. Vafai, E. Shahinfard, K. Ju-Chieh Cheng, J. Mckenzie, N. Neilson, Q. Miao, H. Shinotoh, M. Higuchi, A. Stoessl (Vancouver, BC, Canada)
123I-FP-CIT SPECT imaging in early PD patients versus mid and late onset PD: Longitudinal data from the PPMI study

C. Koros, A. Simitsi, M. Stamelou, A. Prentakis, A. Bougea, I. Pachi, D. Papadimitriou, I. Beratis, N. Papagiannakis, E. Angelopoulou, S. Papageorgiou, X. Geronicola Trapali, L. Stefanis (Athens, Greece)
131-MIBG is less promising in differentiating Parkinson’s disease from other parkinsonism for early onset patients

D. Xu, WJ. Zhu, H. Wang, L. Huo (Beijing, China)
18F-DPA714 PET reveals neuroinflammatory activity in the Substantia nigra of patients with Parkinson disease

S. Lavisse, C. Wimberley, S. Goutal, M. Bottlaender, B. Kuhnast, MA. Peyronneau, M. Sarazin, P. Hantraye, C. Thiriez, P. Remy (Fontenay Aux Roses, France)
3 Year QoL Results for PD Patients Receiving DBS: Product Surveillance Registry

M. Schiess, S. Palfi, J. Azulay, A. Lopez Rios, H. Xiong, K. Sandberg, JK. Krauss (Houston, TX, USA)
5 cases Static Encephalopathy of childhood with NeuroDegeneration in Adulthood (OMIM 300894) in children

M. Bobylova, N. Perumova, T. Prygunova, K. Mukhin (Moscow, Russian Federation)
7,8- Dihydroxyflavone prevents 3-NitropropionicAcid (3-NP)-induced Striatal Toxicity by Modulating the TrkB receptor and Microglial Activation Pathway

S. Ahmed, M. Kwatra, VGM. Naidu (Kamrup, India)
A case of Aceruloplasminemia with vertical saccadic eye movement abnormalities

O. Dogu, N. öksüz, H. Kaleagasi (Mersin, Turkey)
A case of cerebellar ataxia caused by Pembrolizumab for Non-small cell lung cancer

T. Moto, H. Nagayama, K. Kimura (Tokyo, Japan)
A Case of Diurnally Variable Gut Discomfort in a Patient with RLS

J. Coleman, A. Amara (Birmingham, AL, USA)